A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of a safety run-in—A trial of the ECOG-ACRIN Cancer Research Group (EA2174).
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.4064
Abstract: 4064 Background: E/GEJ adenocarcinoma has a high mortality rate despite curative intent therapy. The use of immune checkpoint inhibition is beneficial for treatment of this cancer in the metastatic and adjuvant settings but the role… read more here.
Keywords: safety run; arm; gej adenocarcinoma; trial ... See more keywords
Predictors of clinical outcomes in patients undergoing curative treatment for esophageal or gastroesophageal junction adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e16067
Abstract: e16067 Background: Management of locally advanced esophageal and gastroesophageal junction (E/GEJ) adenocarcinoma is typically managed with neoadjuvant treatment followed by surgery. Clinical outcomes remain suboptimal and a considerable proportion of patients develop recurrence. However, prognostic… read more here.
Keywords: recurrence; esophageal gastroesophageal; treatment; gej adenocarcinoma ... See more keywords
Surgical Treatment of Gastroesophageal Junction Cancer
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Gastric Cancer"
DOI: 10.5230/jgc.2018.18.e28
Abstract: Although the incidence of gastroesophageal junction (GEJ) adenocarcinoma has been increasing worldwide, no standardized surgical strategy for its treatment has been established. This study aimed to provide an update on the surgical treatment of GEJ… read more here.
Keywords: surgical treatment; gej adenocarcinoma; treatment; gastroesophageal junction ... See more keywords